Salmeterol Hydroxynapthoate CAS 94749-08-3

Pwodwi deskripsyon

Non pwodwi: Salmeterol Hydroxynapthoate CAS 94749-08-3

 

 

Synonyms:

2-(hydroxymethyl)-4-[1-idroksile-2-[6-(4-phenylbutoxy) hexylamino] etilik] fenol, 1-hydroxynaphthalene-2-carboxylic asid;

1-hydroxynaphthalene-2-carboxylic asid-2-(hydroxymethyl)-4-(1-idroksile-2-{[6-(4-phenylbutoxy) hexyl] amine} etilik) fenol (1:1);

 

 

Chimik & pwopriyete fizik

Aparans: blan solid

Épreuves: ≥ 99,0%

Dansite: 1.112 g/cm3

Bouyi pwen: 603 ° c nan 760 mmHg ° c

Flash pwen: 318.5 ° c

Ki ap fonn pwen: 137-138 ° c

 

 

Salmeterol xinafoate se yon long-aji BETA-2 adrenergic récepteurs (β2AR) agonist, ak ki nan 1,5 nM pou WT β2AR, ak itilize pou tretman opresyon.

 

 

Si ou enterese nan pwodwi nou yo oswa gen nenpot kesyon, tanpri santi yo lib yo kontakte nou!

 

 

Pwodwi anba patant yo ofri pou R & D objektif selman. Sepandan, responsablite final la manti selman avek achte a.

 

 

 

Baj popilè: salmeterol hydroxynapthoate cas 94749-08-3, manifaktire, founise, faktori, achte, nan Stock

• On: N-benzil-6- (4-phenylbutoxy) hexan-1-amine-oksalat CAS 1070788-08-7
• Pwochen: 1 - (2, 3-Dichlorophenyl) piperazin monokloroksid CAS 11953 2 - 2 6 - 2